Olon Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TRIFAROTENE, with a corresponding US DMF Number 37099.
Remarkably, this DMF maintains an Active status since its submission on May 30, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 19, 2022, and payment made on May 31, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II